PISKEL KYLE Insider Trades

Insider Trading History

Track insider trading activity for PISKEL KYLE. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.42M 256,725 shares
Last Trade
May 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.6k 3,115 shares
$13.04
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.48M 259,840 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$246k 18,672 shares
$13.17
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.8M 278,512 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 61,875 shares
$16.44
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $3.77M 218,782 shares
Last Trade
Feb 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.5k 2,145 shares
$17.01
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $37k 2,146 shares
Last Trade
Feb 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.5k 2,145 shares
$17.01
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $3.73M 216,637 shares
Last Trade
Feb 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.6k 2,145 shares
$18.46
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $73.9k 4,291 shares
Last Trade
Jan 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.3k 4,290 shares
$18.26
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $3.81M 220,927 shares
Last Trade
Jan 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.3k 4,290 shares
$18.26
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $3.73M 216,637 shares
Last Trade
Jan 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.2k 4,290 shares
$18.00
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.7k 3,750 shares
$19.66
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $6.54M 379,457 shares
Last Trade
Nov 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.86M 94,384 shares
$19.66
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.91M 285,073 shares
Last Trade
Nov 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.7k 3,750 shares
$19.66
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.85M 281,323 shares
Last Trade
Nov 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$236k 11,980 shares
$19.66
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $3.73M 216,637 shares
Last Trade
Nov 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.17M 162,820 shares
$19.50
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $148k 8,581 shares
Last Trade
Nov 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.86M 94,384 shares
$19.66
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$236k 11,980 shares
$19.66
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.64M 269,343 shares
Last Trade
Nov 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.34k 238 shares
$14.05
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.78M 277,396 shares
Last Trade
May 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.1k 1,929 shares
$8.89
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.64M 269,581 shares
Last Trade
May 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.1k 1,929 shares
$8.89
$17.23
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Financial Officer
Holding Value $4.81M 279,325 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.6k 7,815 shares
$8.91
$17.23

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up